Clinical trial
ANRS HB07 IP-Cure-B Proof of Concept (PoC) Clinical Trial. Educating the Liver Immune Environment Through TLR8 Stimulation Followed by NUC Discontinuation
NCT05045261 is registered in ClinicalTrials.gov with ANRS, Emerging Infectious Diseases as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- ANRS HB07 IP-Cure-B Proof of Concept (PoC) Clinical Trial. Educating the Liver Immune Environment Through TLR8 Stimulation Followed by NUC Discontinuation
- Lead sponsor
- ANRS, Emerging Infectious Diseases
- Phase
- Phase 2
- Overall status
- Unknown status
- Start date
- February 1, 2022
- Completion date
- June 30, 2024
- Enrollment
- 100 (estimated)
- Sites
- 8
Conditions
As the registry lists them; a condition with its own page is linked.